BioCardia Inc logo

BCDA - BioCardia Inc News Story

$4.2 0.2  4.7%

Last Trade - 9:00pm

Sector
Healthcare
Size
Micro Cap
Market Cap £47.7m
Enterprise Value £32.1m
Revenue £106k
Position in Universe 5462nd / 6841

BRIEF-Biocardia Announces Positive DSMB Review And Recommendation To Continue Phase III Pivotal CardiAMP Heart Failure Study As Designed

Thu 17th December, 2020 1:37pm
Dec 17 (Reuters) - BioCardia Inc  BCDA.O :
    * BIOCARDIA ANNOUNCES POSITIVE DSMB REVIEW AND
RECOMMENDATION TO
CONTINUE PHASE III PIVOTAL CARDIAMP HEART FAILURE STUDY AS
DESIGNED

Source text for Eikon:  ID:nGNXxXsZf 
Further company coverage:  BCDA.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.